hormone-refractory
Showing 1 - 25 of >10,000
Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))
Terminated
- Refractory Cancer
- BIBW 2992 (Afatinib)
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Jun 29, 2022
Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)
Recruiting
- Metastatic Hormone Refractory Prostate Cancer
- Cabozantinib
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 6, 2022
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,
Not yet recruiting
- Androgen-Independent Prostatic Cancer
- +8 more
- lorigerlimab
- +2 more
- (no location specified)
May 4, 2023
Sinusitis Trial in Beijing (Mometasone furoate nasal spray hormone, Mometasone furoate nasal spray hormone + oral hormone,
Recruiting
- Sinusitis
- Mometasone furoate nasal spray hormone
- +2 more
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
May 21, 2022
Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- ARAT
- +2 more
-
Orange City, Florida
- +1 more
Nov 23, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer
Recruiting
- Metastatic Breast Cancer
- +2 more
- Palbociclib
- +2 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center
Jan 17, 2022
Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the
Completed
- Triple Negative Breast Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 17, 2021
Prostate Cancer Trial in Canada, United States (LBH589 (i.v. panobinostat))
Completed
- Prostate Cancer
- LBH589 (i.v. panobinostat)
-
Rockville, Maryland
- +8 more
Dec 16, 2020
Gout Trial in Shanghai (Adrenocorticotropic Hormone, Methylprednisolone Injection)
Recruiting
- Gout
- Adrenocorticotropic Hormone
- Methylprednisolone Injection
-
Shanghai, Shanghai, ChinaShanghai Tenth People's hospital
Mar 19, 2021
Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)
Completed
- Hormone Refractory Prostate Cancer
-
Seoul, Chongro-ku, Korea, Republic of
- +1 more
Feb 16, 2021
Prostate Cancer Trial in Omaha (HyperAcute-Prostate Cancer Vaccine)
Completed
- Prostate Cancer
- HyperAcute-Prostate Cancer Vaccine
-
Omaha, NebraskaUniversity of Nebraska Medical Center
May 26, 2020
Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- GnRH agonist/antagonist
- +3 more
-
Los Angeles, California
- +3 more
Apr 30, 2021
Metastatic Hormone Refractory Prostate Cancer Trial in Worldwide (Patupilone, prednisone, docetaxel)
Completed
- Metastatic Hormone Refractory Prostate Cancer
- Patupilone
- +2 more
-
La Jolla, California
- +31 more
Dec 11, 2020
Prostate Cancer Trial in Los Angeles (carboplatin, paclitaxel)
Completed
- Prostate Cancer
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Aug 17, 2020
Prostate Cancer Trial in Canada (GTI-2040, docetaxel, prednisone)
Completed
- Prostate Cancer
- GTI-2040
- +2 more
-
Vancouver, British Columbia, Canada
- +4 more
Apr 23, 2021
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,
Unknown status
- Estrogen Receptor Negative
- +9 more
- Capecitabine
- +2 more
-
Chicago, Illinois
- +1 more
Jun 25, 2020
Prostate Carcinoma Metastatic to the Bone, Stage IV Prostate Adenocarcinoma, Hormone-refractory Prostate Cancer Trial in United
Active, not recruiting
- Prostate Carcinoma Metastatic to the Bone
- +2 more
- Niraparib
- Radium Ra 223 Dichloride
-
Birmingham, Alabama
- +5 more
Feb 10, 2021